These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 11704395

  • 1. The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial.
    Zeymer U, Suryapranata H, Monassier JP, Opolski G, Davies J, Rasmanis G, Linssen G, Tebbe U, Schröder R, Tiemann R, Machnig T, Neuhaus KL, ESCAMI Investigators.
    J Am Coll Cardiol; 2001 Nov 15; 38(6):1644-50. PubMed ID: 11704395
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A unicenter, randomized, double-blind, parallel-group, placebo-controlled study of Melatonin as an Adjunct in patients with acute myocaRdial Infarction undergoing primary Angioplasty The Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty (MARIA) trial: study design and rationale.
    Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ, Kaski JC, Reiter RJ, Jimenez-Sosa A.
    Contemp Clin Trials; 2007 Jul 15; 28(4):532-9. PubMed ID: 17123867
    [Abstract] [Full Text] [Related]

  • 4. Randomized controlled trial of TY-51924, a novel hydrophilic NHE inhibitor, in acute myocardial infarction.
    Kimura K, Nakao K, Shibata Y, Sone T, Takayama T, Fukuzawa S, Nakama Y, Hirayama H, Matsumoto N, Kosuge M, Hiro T, Sakuma H, Ishihara M, Asakura M, Hamada C, Kaneko A, Yokoi T, Hirayama A, AMITY study group.
    J Cardiol; 2016 Apr 15; 67(4):307-13. PubMed ID: 26359711
    [Abstract] [Full Text] [Related]

  • 5. Sodium-hydrogen exchange inhibition: novel strategy to prevent myocardial injury following ischemia and reperfusion.
    Buerke M, Rupprecht HJ, vom Dahl J, Terres W, Seyfarth M, Schultheiss HP, Richardt G, Sheehan FH, Drexler H.
    Am J Cardiol; 1999 May 20; 83(10A):19G-22G. PubMed ID: 10482176
    [Abstract] [Full Text] [Related]

  • 6. Na+/H+ exchange inhibition with cardioplegia reduces cytosolic [Ca2+] and myocardial damage after cold ischemia.
    Camara AK, An J, Chen Q, Novalija E, Varadarajan SG, Schelling P, Stowe DF.
    J Cardiovasc Pharmacol; 2003 May 20; 41(5):686-98. PubMed ID: 12717098
    [Abstract] [Full Text] [Related]

  • 7. Primary percutaneous transluminal coronary angioplasty accelerates early myocardial reperfusion compared to thrombolytic therapy in patients with acute myocardial infarction.
    Zeymer U, Schröder R, Machnig T, Neuhaus KL.
    Am Heart J; 2003 Oct 20; 146(4):686-91. PubMed ID: 14564324
    [Abstract] [Full Text] [Related]

  • 8. Dose-dependent reduction of myocardial infarct mass in rabbits by the NHE-1 inhibitor cariporide (HOE 642).
    Linz W, Albus U, Crause P, Jung W, Weichert A, Schölkens BA, Scholz W.
    Clin Exp Hypertens; 1998 Oct 20; 20(7):733-49. PubMed ID: 9764718
    [Abstract] [Full Text] [Related]

  • 9. Trial design and rationale of TY-51924 as a novel Na+/H+ exchanger inhibitor in patients with ST-elevation acute myocardial infarction undergoing percutaneous coronary intervention.
    Ishihara M, Asakura M, Kimura K, Nakao K, Hamada C, Hirayama A.
    J Cardiol; 2014 Jan 20; 63(1):82-7. PubMed ID: 23860273
    [Abstract] [Full Text] [Related]

  • 10. Cardioprotective therapy and sodium-hydrogen exchange inhibition: current concepts and future goals.
    Menown IB, Adgey AA.
    J Am Coll Cardiol; 2001 Nov 15; 38(6):1651-3. PubMed ID: 11704376
    [No Abstract] [Full Text] [Related]

  • 11. GUARD During Ischemia Against Necrosis (GUARDIAN) trial in acute coronary syndromes.
    Erhardt LR.
    Am J Cardiol; 1999 May 20; 83(10A):23G-25G. PubMed ID: 10482177
    [Abstract] [Full Text] [Related]

  • 12. Population pharmacokinetics of eniporide and its metabolite in healthy subjects and patients with acute myocardial infarction.
    Bhattaram VA, Nagaraja NV, Peters T, Machnig T, Kroesser S, Kovar A, Derendorf H.
    J Clin Pharmacol; 2005 Jun 20; 45(6):631-9. PubMed ID: 15901744
    [Abstract] [Full Text] [Related]

  • 13. A randomized double-blind trial of intravenous trimetazidine as adjunctive therapy to primary angioplasty for acute myocardial infarction.
    Steg PG, Grollier G, Gallay P, Morice M, Karrillon GJ, Benamer H, Kempf C, Laperche T, Arnaud P, Sellier P, Bourguignon C, Harpey C, LIST Study Group.
    Int J Cardiol; 2001 Feb 20; 77(2-3):263-73. PubMed ID: 11182191
    [Abstract] [Full Text] [Related]

  • 14. Pharmacology and clinical assessment of cariporide for the treatment coronary artery diseases.
    Karmazyn M.
    Expert Opin Investig Drugs; 2000 May 20; 9(5):1099-108. PubMed ID: 11060730
    [Abstract] [Full Text] [Related]

  • 15. Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
    Direct Inhibition of delta-Protein Kinase C Enzyme to Limit Total Infarct Size in Acute Myocardial Infarction (DELTA MI) InvestigatorsDuke Clinical Research Institute, 2400 Pratt St, Room 7035, Durham, NC 27705. matthew.roe@duke.edu., Bates E, Bode C, Costa M, Gibson CM, Granger C, Green C, Grimes K, Harrington R, Huber K, Kleiman N, Mochly-Rosen D, Roe M, Sadowski Z, Solomon S, Widimsky P.
    Circulation; 2008 Feb 19; 117(7):886-96. PubMed ID: 18250271
    [Abstract] [Full Text] [Related]

  • 16. Na(+)/H(+) exchange inhibitors for cardioprotective therapy: progress, problems and prospects.
    Avkiran M, Marber MS.
    J Am Coll Cardiol; 2002 Mar 06; 39(5):747-53. PubMed ID: 11869836
    [Abstract] [Full Text] [Related]

  • 17. Na(+)/H(+) exchange inhibition prevents endothelial dysfunction after I/R injury.
    Gumina RJ, Moore J, Schelling P, Beier N, Gross GJ.
    Am J Physiol Heart Circ Physiol; 2001 Sep 06; 281(3):H1260-6. PubMed ID: 11514295
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of the safety and efficacy of TY-51924 in patients with ST elevated acute myocardial infarction - Early phase II first in patient pilot study.
    Takayama T, Kimura K, Fukuzawa S, Hirayama H, Sone T, Ueda Y, Uematsu M, Ishihara M, Nakao K, Matsumoto N, Kosuge M, Hiro T, Asakura M, Kaneko A, Yokoi T, Hirayama A.
    J Cardiol; 2016 Feb 06; 67(2):162-9. PubMed ID: 25982669
    [Abstract] [Full Text] [Related]

  • 19. In vitro and in vivo pharmacology of a structurally novel Na+-H+ exchange inhibitor, T-162559.
    Kusumoto K, Igata H, Abe A, Ikeda S, Tsuboi A, Imamiya E, Fukumoto S, Shiraishi M, Watanabe T.
    Br J Pharmacol; 2002 Apr 06; 135(8):1995-2003. PubMed ID: 11959803
    [Abstract] [Full Text] [Related]

  • 20. Estimation of enzymatic infarct size: direct comparison of the marker enzymes creatine kinase and alpha-hydroxybutyrate dehydrogenase.
    Dissmann R, Linderer T, Schröder R.
    Am Heart J; 1998 Jan 06; 135(1):1-9. PubMed ID: 9453514
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.